AU2012279752A1 — Applicator
Assigned to Kaken Pharmaceutical Co Ltd · Expires 2013-12-19 · 12y expired
What this patent protects
[Problem] To provide a liquid applicator with which irritation on an affected part of a patient may be reduced even when a liquid drug is used. [Solution] According to the present invention, an applicator comprises a solution container which comprises an opening, and a columnar b…
USPTO Abstract
[Problem] To provide a liquid applicator with which irritation on an affected part of a patient may be reduced even when a liquid drug is used. [Solution] According to the present invention, an applicator comprises a solution container which comprises an opening, and a columnar brush member formed by bundling synthetic fibers in a columnar shape. The columnar brush member is disposed at the opening of the solution container, a tip portion of the columnar brush member at an outside of the solution container has a fan shape expanding in a perpendicular lateral direction against a pillar axial lengthwise direction, and a thickness of the fan-shaped tip portion of the columnar brush member decreases in a perpendicular lengthwise direction against the pillar axial lengthwise direction toward the tip portion of the columnar brush member. The liquid applicator of the present invention has the fan-shaped tip portion so that irritation on an affected part may be decreased and a liquid tinea medicine may be applied to the affected part.
Drugs covered by this patent
- Jublia (EFINACONAZOLE) · Bausch Health
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.